Live Quote · NASDAQALKSHealthcare· Drug Manufacturers - Specialty & Generic

Alkermes plc

$44.94▼ 2.69%($-1.24)
MKT CAP $7.55BNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
56/100
▌ Mixed
52
Valuation
40
Profitability
10
Growth
76
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALKS research report →

Analyst Price Target
$58.70+30.6% vs. today

Range $50 – $68

Analyst RatingBuy
16 Buy10 Hold3 Sell

Price Chart

+64.42% · this period
$55.22$41.21$27.20Nov 20May 26Nov 20
52-Week Range63% of range
Low
$27.00
Current
$44.94
High
$55.67